PT - JOURNAL ARTICLE AU - Arndt, Leandra AU - Koleala, Tamarah AU - Orbán, Ágnes AU - Ibam, Clemencia AU - Timinao, Lincoln AU - Lorry, Lina AU - Butykai, Ádám AU - Kaman, Peter AU - Molnár, Andrea P. AU - Krohns, Stephan AU - Nate, Elma AU - Kucsera, István AU - Orosz, Erika AU - Moore, Brioni AU - J Robinson, Leanne AU - Laman, Moses AU - Kézsmárki, István AU - Karl, Stephan TI - Magneto-optical diagnosis of symptomatic malaria in Papua New Guinea AID - 10.1101/2020.05.14.20101543 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.14.20101543 4099 - http://medrxiv.org/content/early/2020/05/19/2020.05.14.20101543.short 4100 - http://medrxiv.org/content/early/2020/05/19/2020.05.14.20101543.full AB - Improved methods for malaria diagnosis are urgently needed. Here, we evaluated a novel diagnostic test named rotating-crystal magneto-optical detection (RMOD) in 964 suspected malaria patients in Papua New Guinea. RMOD tests can be obtained within minutes and at low cost. Capillary blood samples were also subjected to rapid diagnostic tests, expert light microscopy and polymerase chain reaction to systematically evaluate the capability of RMOD to detect infections. Compared to light microscopy, as the gold standard, RMOD exhibited 82% sensitivity and 84% specificity to detect any malaria infection. This increased to 87% sensitivity and 88% specificity for Plasmodium vivax, indicating that RMOD could be useful in P. vivax dominated elimination settings. Parasite density correlated well with the quantitative magneto-optical signal. Importantly, residual hemozoin present in malaria negative patients was also detectable by RMOD, indicating its ability to detect previous infections, which can be exploited to reveal transmission hotspots in low-transmission settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSK (GNT1141441) and LJR (GNT1161627) are recipients of an Australian National Health and Medical Research Council (NHMRC) Career Develop-ment Fellowship. This study was funded by NHMRC Project Grant (GNT1127356). AB and AO were supported by the BME-Nanonotechnology and Materials Science FIKP grant of EMMI (BME FIKP-NAT). LT is supported by a James Cook University PhD scholarship.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available by the corresponding authors upon request